AlzChem Group AG (ETR: ACT)

Market Cap	580.05M
Revenue (ttm)	563.55M
Net Income (ttm)	50.10M
Shares Out	10.18M
EPS (ttm)	4.93
PE Ratio	11.57
Forward PE	10.63
Dividend	1.20 (2.11%)
Ex-Dividend Date	n/a

Volume	7,184
Open	57.60
Previous Close	58.20
Day's Range	55.20 - 58.20
52-Week Range	22.20 - 64.80
Beta	1.01
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 28, 2025

About AlzChem Group AG

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1908
• Employees: 1,708
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: ACT

Financial Performance

In 2023, AlzChem Group AG's revenue was 545.79 million, a decrease of -0.68% compared to the previous year's 549.53 million. Earnings were 34.62 million, an increase of 15.20%.